|
CDC16 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.36770000000042E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.363600E-04 |
| Normal-vs-Stage2 |
5.561900E-02 |
| Normal-vs-Stage3 |
5.365200E-01 |
| Normal-vs-Stage4 |
2.265400E-01 |
| Stage1-vs-Stage2 |
5.536600E-01 |
| Stage1-vs-Stage3 |
1.298360E-01 |
| Stage1-vs-Stage4 |
6.995800E-01 |
| Stage2-vs-Stage3 |
1.676750E-01 |
| Stage2-vs-Stage4 |
5.102800E-01 |
| Stage3-vs-Stage4 |
6.064600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.167900E-04 |
| Normal-vs-AfricanAmerican |
1.837490E-04 |
| Normal-vs-Asian |
1.932020E-01 |
| Caucasian-vs-AfricanAmerican |
8.802400E-02 |
| Caucasian-vs-Asian |
7.814200E-01 |
| AfricanAmerican-vs-Asian |
4.334200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.424700E-04 |
| Normal-vs-Female |
1.361730E-03 |
| Male-vs-Female |
5.130200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.146470E-02 |
| Normal-vs-Extreme_Weight |
1.038240E-02 |
| Normal-vs-Obese |
3.498000E-03 |
| Normal-vs-Extreme_Obese |
7.808100E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.031800E-01 |
| Normal_Weight-vs-Obese |
8.502400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.943400E-01 |
| Extreme_Weight-vs-Obese |
3.624600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.205800E-01 |
| Obese-vs-Extreme_Obese |
7.215800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.048400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.46919999949513E-07 |
| Normal-vs-Age(61-80Yrs) |
9.097100E-03 |
| Normal-vs-Age(81-100Yrs) |
7.760800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.527900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.916400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.200200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.098100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.282300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.819000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.35869999981797E-07 |
| Normal-VS-Type2 PRCC |
1.777970E-01 |
| Normal-VS-KIRP CIMP |
9.343200E-03 |
| Normal-VS-Unclassified PRCC |
2.312100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.257700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.203860E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.849000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.247700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.511640E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.435800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.299700E-02 |
| Normal-vs-N1 |
1.840010E-01 |
| Normal-vs-N2 |
3.047600E-01 |
| N0-vs-N1 |
7.187600E-01 |
| N0-vs-N2 |
3.744300E-02 |
| N1-vs-N2 |
1.175820E-01 |
|
|
